Johnson & Johnson
Wednesday, June 05, 2024
Company Presentation
Multiple Therapeutics
Company Presentation Theater 2
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Come hear Stacy Feld share more about Johnson & Johnson’s partnering model and priority areas of interest. Learn more at https://www.jnj.com/.
Company Website:
http://www.jnjinnovation.com
Lead Product in Development:
Stelara, Darzalex, Imbruvica, Tremfya, Erleada, Xarelto
Exchange
JNJ
Ticker
JNJ
Company HQ City
New Brunswick
Company HQ State
NJ
Company HQ Country
United States
CEO/Top Company Official
Joaquin Duato
Development Phase of Primary Product
Multiple Products in Market
Speakers